Tag: Jay Amsterdam
Investigators Who Blew the Whistle On STAR*D Fraud Call for Retraction...
A letter that Ed Pigott and Jay Amsterdam sent to Ned Kalin, editor-in-chief of the American Journal of Psychiatry.
New Data Reveal the Full Extent of STAR*D Failure
The initial study, which has been used to promote antidepressants, employed outcome switching to hide poor results.
Amsterdam Files New Study 352 Whistleblower Complaint
Jay Amsterdam, who first blew the whistle on corrupt research practices in a study conducted by GlaxoSmithKline (GSK) eight years ago, has now submitted...
Researchers Expose Pharmaceutical Industry Misconduct and Corruption
Corruption of pharmaceutical industry sponsored clinical trials identified as a “major obstacle” facing evidence-based medicine.
Ghostwriting: Time for a Name Change
There is a fascinating process playing out in academic medicine right now. The general public is understandably concerned that much of the medical literature...
